Sign inJoin waitlistJoin the waitlist

JE

Jailan Elayoubi

Physician · Wayne State University School of Medicine

Credentials: · · · · ·

History

Wayne State University School of Medicine
2020–Present

Hematology and Medical Oncology
McLaren Health Care Corporation
2016–2019
Internal Medicine
2006–2009
Doctor of Medicine
2002–2006

Research

MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world data
JNCI Cancer Spectrum · 2025 · 8 citations
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
Cancer Research Communications · 2024 · 5 citations
Multi-modal AI for comprehensive breast cancer prognostication
Nature Communications · 2026 · 4 citations

AB
Adam Brufsky
2 papers
FE
Francisco Esteva
2 papers
JC
Joseph Cappadona
2 papers
KC
Khalil Choucair
2 papers
Yu Zong
2 papers · 2 as a resident
AA
Abdurahman Alloghbi
1 paper · 1 as a fellow
AS
Alfredo Santillan-Gomez
1 paper
AS
Ammar Sukari
1 paper
AS
Anas Saad
1 paper · 1 as a resident
Andrew Clayburn
1 paper · 1 as a resident
AS
Anthony Shields
1 paper
BA
Bassel Atassi
1 paper

Clinical trials

Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression
Principal investigator · Not yet recruiting
Barbara Ann Karmanos Cancer Institute
2026–2028
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Site PI · Recruiting
Natera, Inc.
2026–2037
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2032